Traduction de «E114 form » (Anglais → Néerlandais) :

TERMINOLOGIE

E114 form | granting of major benefits in kind
fromulier E114 | verstrekking van prothesen,hulpmiddelen van grotere omvang,enz.

cutting vacuum formed workpiece | trim vacuum formed workpiece | cut vacuum formed workpiece | trimming vacuum formed workpiece
thermogevormd werkstuk bijsnijden | thermogevormd werkstuk op maat snijden | vacuümgevormd werkstuk bijsnijden | vacuümgevormd werkstuk op maat snijden

complete an evaluation form of a call | completing evaluation forms of calls | carry out evaluation forms of calls | complete evaluation forms of calls
evaluatieformulieren van oproepen invullen

fill-in form | fill-out form | interactive form | Web form
webformulier

dosage form | pharmaceutical dosage form | pharmaceutical dose form | pharmaceutical form
afleveringsvorm | dispenseervorm | doseringsvorm | farmaceutische vorm | handelsvorm | toedieningsvorm

create vacuum forming mould | make vacuum forming mould | create vacuum forming mould | creating vacuum forming mold
matrijs voor thermovormen maken | matrijs voor vacuümvormen maken | mal voor thermovormen maken | mal voor vacuümvormen maken

An intermediate form of lichen myxedematosus (a form of mucin dermal deposit) which does not meet the criteria for either scleromyxedema or the localized form. Three clinical subtypes have been described and include scleromyxedema without monoclonal
atypische lichen myxoedematosus

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...
Omschrijving: Dit blok omvat een grote verscheidenheid van stoornissen van verschillende ernst en klinische vorm, die evenwel alle aan het gebruik van een of meer psychoactieve middelen, al dan niet op medisch voorschrift, zijn toe te schrijven. De betrokken stof wordt aangegeven door middel van het derde teken van de code en het vierde teken specificeert de klinische toestand; deze codering dient, waar nodig, gebruikt te worden voor elk gespecificeerd middel, met dien verstande dat niet elk vierde teken van toepassing is op elke stof.

An X-linked disorder of purine metabolism comprised of two forms: an early-onset severe form with characteristics of gout, urolithiasis, and neurodevelopmental anomalies (severe PRPP synthetase superactivity) and a mild late-onset form with no neurol
fosforibosylpyrofosfaatsynthetase-superactiviteit

A mitochondrial disease with characteristics of cataracts, hypertrophic cardiomyopathy, muscle weakness and lactic acidosis after exercise. May present in two forms, a neonatal lethal form or a chronic form. Hypertrophic cardiomyopathy is diagnosed a
syndroom van Sengers

TRADUCTIONS EN CONTEXTE

4.83: Decision No 198 of 23 March 2004 concerning the replacement and abolition of the model forms necessary for the implementation of Council Regulations (EEC) No 1408/71 and (EEC) No 574/72 (E110, E111, E111B, E113, E114, E119, E128, E128B) (OJ L 259, 5.8.2004, p. 1)’
4.83: Besluit nr. 198 van 23 maart 2004 betreffende de vervanging en de intrekking van de modelformulieren voor de toepassing van de verordeningen (EEG) nr. 1408/71 en (EEG) nr. 574/72 (E110, E111, E111B, E113, E114, E119, E128 en E128B) (PB L 259 van 5.8.2004, blz. 1)”.